Mr Hobbs is president and CEO of AngioDynamics, a medical device company specializing in the development and sales of medical technology serving the needs of interventional oncologists and vascular interventionalists.
Richard Taney, president and CEO of Delcath, said: “We are delighted to have Eamonn join the board of directors of Delcath. His successful leadership of AngioDynamics, his experience within the medical device industry and his involvement in a number of medical organizations make him a welcome addition to our board of directors.”